Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Opiant Pharmaceuticals Inc (NASDAQ:OPNT)

30.80
Delayed Data
As of Oct 23
 -1.20 / -3.75%
Today’s Change
5.00
Today|||52-Week Range
51.90
+449.02%
Year-to-Date
No recent news for Opiant Pharmaceuticals Inc.

Today’s Trading

Previous close32.00
Today’s open32.56
Day’s range30.54 - 36.44
Volume27,829
Average volume (3 months)61,799
Market cap$65.2M
Dividend yield--
Data as of 3:59pm ET, 10/23/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+86.37%
P/E ratio9.5
Price/Sales1.58
Price/Book14.96

Competitors

 Today’s
change
Today’s
% change
APDNApplied DNA Sciences...-0.05-2.11%
XENEXenon Pharmaceutical...-0.15-4.62%
PLXPPLX Pharma Inc+0.40+4.60%
CASICASI Pharmaceuticals...+0.12+5.06%
Data as of 3:59pm ET, 10/23/2017

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$18.4M
Annual profit (last year)$6.6M
Net profit margin35.68%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Director &
Head-Media Relations
Roger Crystal
Chief Financial Officer
David D. O'Toole
Corporate headquarters
Santa Monica, California

Forecasts